The best treatment for high-grade T1 bladder cancer is cystectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 6, 2007, Pages 523-525

  Skinner, Eila C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder cancer; Cystectomy; G3T1

Indexed keywords

BLADDER CANCER; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; CYSTECTOMY; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; ALGORITHMS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; CYSTECTOMY; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 36348967130     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.05.023     Document Type: Review

References (16)

1. Shahin O., Thalmann G.N., Rentsch C., et al. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guérin for primary stage T1 grade 3 bladder cancer: Recurrence, progression, and survival. J Urol 169 (2003) 96-100
2. Pansodoro P., Emiliozzi P., de Paula F., et al. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin: 18-year experience. Urology 59 (2002) 227-231
3. Brake M., Loertzer H., Horsch R., et al. Recurrence and progression of stage T1 grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guérin. J Urol 163 (2000) 1697-1701
4. Orsola A., Trias I., Raventos C.X., et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-nontreated patients. Eur Urol 48 (2005) 231-238
5. Van der Meidjian A., Sylvester R., Collette L., et al. Role and impact of pathology review on stage and grade assessment of stages T1 and T1 bladder tumors: Combined analysis of 5 European Organization for Research and Treatment of Cancer trials. J Urol 164 (2000) 1533-1537
6. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis, and T1 transitional cell carcinoma of the bladder. J Urol 151 (1994) 31-35
7. Nieder A.M., Simon M.A., Kim S.S., et al. Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: Defining the risk of initial bladder preservation. Urology 67 (2006) 737-741
8. Bianco Jr. F.J., Justa D., and Grignon D.J. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 22 (2004) 290-294
9. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74-76
10. Dutta S.C., Smith Jr. J.A., Shappell S.B., et al. Clinical under staging of high risk non-muscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490-493
11. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
12. Cookson M.S., Herr H.W., Zhang Z.F., et al. The treatment natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158 (1997) 62-67
13. Thalmann G.N., Markwalder R., Shahin O., et al. Primary T1G3 bladder cancer: Organ preserving approach or immediate cystectomy?. J Urol 172 (2004) 70-75
14. Hurle R., Losa A., Manzetti A., et al. Intravesical bacilli Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: A 7-year follow-up. Urology 54 (1999) 258-263
15. Sylvester R.J., Oosterlinck W., and van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials. J Urol 171 (2004) 2186-2190
16. Solsona E., Iborra I., Dumon R., et al. The 3-month clinical response to intravesical therapy as predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 164 (2000) 685-689